Cite
Martelli MP, Rossi R, Venanzi A, et al. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML. Blood. 2021;138(25):2696-2701doi: 10.1182/blood.2021012732.
Martelli, M. P., Rossi, R., Venanzi, A., Meggendorfer, M., Perriello, V. M., Martino, G., Spinelli, O., Ciurnelli, R., Varasano, E., Brunetti, L., Ascani, S., Quadalti, C., Cardinali, V., Mezzasoma, F., Gionfriddo, I., Milano, F., Pacini, R., Tabarrini, A., Bigerna, B., Albano, F., Specchia, G., Vetro, C., Di Raimondo, F., Annibali, O., Avvisati, G., Rambaldi, A., Falzetti, F., Tiacci, E., Sportoletti, P., Haferlach, T., Haferlach, C., & Falini, B. (2021). Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML. Blood, 138(25), 2696-2701. https://doi.org/10.1182/blood.2021012732
Martelli, Maria Paola, et al. "Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML." Blood vol. 138,25 (2021): 2696-2701. doi: https://doi.org/10.1182/blood.2021012732
Martelli MP, Rossi R, Venanzi A, Meggendorfer M, Perriello VM, Martino G, Spinelli O, Ciurnelli R, Varasano E, Brunetti L, Ascani S, Quadalti C, Cardinali V, Mezzasoma F, Gionfriddo I, Milano F, Pacini R, Tabarrini A, Bigerna B, Albano F, Specchia G, Vetro C, Di Raimondo F, Annibali O, Avvisati G, Rambaldi A, Falzetti F, Tiacci E, Sportoletti P, Haferlach T, Haferlach C, Falini B. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML. Blood. 2021 Dec 23;138(25):2696-2701. doi: 10.1182/blood.2021012732. PMID: 34343258.
Copy
Download .nbib